Table 3.
Characteristics of the survey population
| Pre-implementation (n=239) | Post-implementation (n=197) | |
| Intake consultations | ||
| Age (yrs) | 53.9 | 55.4 |
| Gender (% male) | 68.4 | 69.5 |
| Severity of symptoms* | 6.50 | 6.44 |
| Diagnosed with OSA (%) | 82.8 | 83.2 |
| CPAP† (%) | 71.0 | 70.7 |
| MRA‡ (%) | 13.7 | 19.5 |
| Other treatment† (%) | 10.7 | 7.4 |
| No treatment† (%) | 1.0 | 2.4 |
| Missing† (%) | 3.6 | 0.0 |
| Pre-implementation (n=248) | Post-implementation (n=180) | |
| Follow-up consultations | ||
| Age (yrs) | 57.33 | 58.54 |
| Gender (% male) | 75.3 | 69.7 |
| Severity of remaining symptoms or problems with treatment* | 4.25 | 5.03 |
| CPAP (%) | 89.1 | 89.4 |
| MRA‡ (%) | 3.6 | 3.9 |
| Other§ or missing (%) | 7 | 5.6 |
*Scale 1–10, higher is more problems.
†Percentage of patients with this treatment of the total of patients diagnosed with OSA.
‡Device worn over the teeth that pushes tongue and jaw forward to hold the airway open.
§Other possible treatments are surgery of the jaw or throat, and methods that will help a patient with positional OSA (who experiences breathing stops mainly when they lie on their backs) sleep on their side.
CPAP, continuous positive airway pressure; MRA, mandibular repositioning device; OSA, obstructive sleep apnoea; yrs, years.